•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S01578 Summary:

BILL NOS01578B
 
SAME ASSAME AS A03676-B
 
SPONSORSANDERS
 
COSPNSRASHBY, CLEARE, COMRIE, FERNANDEZ, GIANARIS, JACKSON, KRUEGER, MAY, MAYER, MYRIE, PARKER, RAMOS, ROLISON, SCARCELLA-SPANTON, SEPULVEDA, WEBB
 
MLTSPNSR
 
Add §2807-bb, amd §3331, Pub Health L
 
Establishes the "Sickle Cell Treatment Act" which designates sickle cell centers for excellence and outpatient treatment centers.
Go to top

S01578 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         1578--B
 
                               2025-2026 Regular Sessions
 
                    IN SENATE
 
                                    January 10, 2025
                                       ___________
 
        Introduced by Sens. SANDERS, ASHBY, CLEARE, COMRIE, FERNANDEZ, GIANARIS,
          JACKSON,  KRUEGER, MAY, MAYER, MYRIE, PARKER, RAMOS, ROLISON, SEPULVE-
          DA, WEBB -- read twice and ordered printed, and  when  printed  to  be
          committed  to  the Committee on Health -- reported favorably from said
          committee and committed to  the  Committee  on  Finance  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to  said  committee  --  committee  discharged,  bill amended, ordered
          reprinted as amended and recommitted to said committee
 
        AN ACT to amend the public health law, in relation to  establishing  the
          "Sickle Cell Treatment Act"
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Short title. This act shall be known and may  be  cited  as
     2  the "Sickle Cell Treatment Act".
     3    §  2. The public health law is amended by adding a new section 2807-bb
     4  to read as follows:
     5    § 2807-bb. Sickle cell centers for excellence and outpatient treatment
     6  centers. 1. Centers for sickle cell care  excellence.  The  commissioner
     7  shall designate five general hospitals or hospices with a minimum of two
     8  centers  north of Putnam and Orange counties under article forty of this
     9  chapter, upon successful application, as centers for  sickle  cell  care
    10  excellence.  The  designations  shall  be  made  through  an application
    11  designed by the department, and based on  service,  staffing  and  other
    12  criteria  as  developed  by  the commissioner. The centers of excellence
    13  shall provide specialized sickle cell disease care,  treatment,  pallia-
    14  tive  care, education and related services and shall conduct specialized
    15  research into the care, treatment and management of sickle cell disease.
    16  Designation as a center for sickle cell care excellence shall not  enti-
    17  tle  a center to enhanced reimbursement, but may be utilized in outreach
    18  and other promotional activities.  Each  center  for  sickle  cell  care
    19  excellence  shall  affiliate  and cooperate with major centers of higher
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD01146-05-5

        S. 1578--B                          2
 
     1  learning, including medical colleges, and life science  research  insti-
     2  tutes  in  the state.  The state university shall enter into appropriate
     3  legal agreements to enable this cooperation. Each center for sickle cell
     4  care  excellence  shall  receive  five hundred thousand dollars per year
     5  from the department, from amounts appropriated for that purpose,  to  be
     6  used on sickle cell disease research.
     7    2.  Outpatient treatment centers. The commissioner shall designate ten
     8  hospitals, distributed based on sickle cell patient  population  concen-
     9  trations,  as  sickle  cell  outpatient  treatment  centers  which shall
    10  provide patients treatment for sickle cell  disease  as  an  outpatient.
    11  Each  sickle  cell outpatient treatment center shall receive two hundred
    12  fifty thousand dollars per year from the department, from amounts appro-
    13  priated for that purpose, to be used to ensure the proper management and
    14  equipping of the centers to care for sickle cell patients.
    15    § 3. Subdivision 8 of section 3331 of the public health law, as  added
    16  by  section  7-a of part D of chapter 57 of the laws of 2018, is amended
    17  to read as follows:
    18    8. No opioids shall be prescribed to a  patient  initiating  or  being
    19  maintained on opioid treatment for pain which has lasted more than three
    20  months  or  past  the  time of normal tissue healing, unless the medical
    21  record contains a written treatment plan that follows generally accepted
    22  national professional or governmental guidelines.  The  requirements  of
    23  this [paragraph] subdivision shall not apply in the case of patients who
    24  are  being  treated  for  sickle  cell  disease or cancer that is not in
    25  remission, who are in hospice or other end-of-life care, or  whose  pain
    26  is being treated as part of palliative care practices.
    27    § 4. This act shall take effect immediately.
Go to top